Lung Adenocarcinoma with Anaplastic Lymphoma Kinase (ALK) Rearrangement Presenting as Carcinoma of Unknown Primary Site: Recognition and Treatment Implications

BACKGROUND: Molecular cancer classifier assays are being used with increasing frequency to predict tissue of origin and direct site-specific therapy for patients with carcinoma of unknown primary site (CUP). OBJECTIVE: We postulated some CUP patients predicted to have non-small-cell lung cancer (NSC...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Drugs Real World Outcomes
Hlavní autoři: Hainsworth, John D., Anthony Greco, F.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2016
Témata:
Original Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4819469/
https://ncbi.nlm.nih.gov/pubmed/27747807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40801-016-0064-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky